Clinical trials
Completed Hypertension, Pulmonary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
490 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 7 |
| 2004 | 7 |
| 2005 | 19 |
| 2006 | 24 |
| 2007 | 19 |
| 2008 | 26 |
| 2009 | 31 |
| 2010 | 23 |
| 2011 | 31 |
| 2012 | 29 |
| 2013 | 18 |
| 2014 | 26 |
| 2015 | 19 |
| 2016 | 30 |
| 2017 | 31 |
| 2018 | 37 |
| 2019 | 20 |
| 2020 | 13 |
| 2021 | 22 |
| 2022 | 9 |
| 2023 | 12 |
| 2024 | 15 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 490 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Zurich | 42 |
| Bayer | 32 |
| United Therapeutics | 17 |
| Medical University of Graz | 13 |
| Actelion | 12 |
| GlaxoSmithKline | 12 |
| National Heart, Lung, and Blood Institute (NHLBI) | 11 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 9 |
| Assistance Publique - Hôpitaux de Paris | 7 |
| Gilead Sciences | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 490 |
| Pulmonary Arterial Hypertension | 87 |
| Heart Failure | 29 |
| Pulmonary Disease, Chronic Obstructive | 27 |
| Hypoxia | 22 |
| Altitude Sickness | 19 |
| Familial Primary Pulmonary Hypertension | 16 |
| Lung Diseases, Interstitial | 16 |
| Anemia, Sickle Cell | 15 |
| Hypertension | 12 |
Trials
Showing 26 to 50 of 490. Each trial links to its page on Pharma Observatory.
390 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.